Sato A - Search Results

1

Nelfinavir and Ritonavir Kill Bladder Cancer Cells Synergistically by Inducing Endoplasmic Reticulum Stress.

Sato A, Asano T, Okubo K, Isono M, Asano T. Sato A, et al. Oncol Res. 2018 Mar 5;26(2):323-332. doi: 10.3727/096504017X14957929842972. Epub 2017 May 26. Oncol Res. 2018. PMID: 28560953 Free PMC article.

2

Synergistic effect of survivin-specific small interfering RNA and topotecan in renal cancer cells: topotecan enhances liposome-mediated transfection by increasing cellular uptake.

Sato A, Ito K, Asano T, Sumitomo M, Asano T, Hayakawa M. Sato A, et al. Int J Oncol. 2007 Mar;30(3):695-700. Int J Oncol. 2007. PMID: 17273771

3

Topotecan and small interfering RNA suppress survivin expression synergistically in Caki-1 renal cancer cells: Direct suppression of survivin and enhancement of transfection efficiency by topotecan.

Sato A, Ito K, Asano T, Sumitomo M, Asano T, Hayakawa M. Sato A, et al. Int J Oncol. 2008 Jan;32(1):171-6. Int J Oncol. 2008. PMID: 18097556

4

Antitumor effect of suberoylanilide hydroxamic acid and topotecan in renal cancer cells.

Sato A, Asano T, Horiguchi A, Ito K, Sumitomo M, Asano T. Sato A, et al. Oncol Res. 2011;19(5):217-23. doi: 10.3727/096504011x12970940207841. Oncol Res. 2011. PMID: 21542457

5

Ritonavir interacts with bortezomib to enhance protein ubiquitination and histone acetylation synergistically in renal cancer cells.

Sato A, Asano T, Ito K, Asano T. Sato A, et al. Urology. 2012 Apr;79(4):966.e13-21. doi: 10.1016/j.urology.2011.11.033. Epub 2012 Jan 30. Urology. 2012. PMID: 22296623

6

17-Allylamino-17-demethoxygeldanamycin and ritonavir inhibit renal cancer growth by inhibiting the expression of heat shock factor-1.

Sato A, Asano T, Ito K, Asano T. Sato A, et al. Int J Oncol. 2012 Jul;41(1):46-52. doi: 10.3892/ijo.2012.1419. Epub 2012 Mar 28. Int J Oncol. 2012. PMID: 22470109

7

Vorinostat and bortezomib synergistically cause ubiquitinated protein accumulation in prostate cancer cells.

Sato A, Asano T, Ito K, Asano T. Sato A, et al. J Urol. 2012 Dec;188(6):2410-8. doi: 10.1016/j.juro.2012.07.108. Epub 2012 Oct 22. J Urol. 2012. PMID: 23088964

8

Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cells.

Sato A, Asano T, Isono M, Ito K, Asano T. Sato A, et al. BMC Urol. 2014 Aug 30;14:71. doi: 10.1186/1471-2490-14-71. BMC Urol. 2014. PMID: 25176354 Free PMC article.

9

Ritonavir acts synergistically with panobinostat to enhance histone acetylation and inhibit renal cancer growth.

Sato A, Asano T, Isono M, Ito K, Asano T. Sato A, et al. Mol Clin Oncol. 2014 Nov;2(6):1016-1022. doi: 10.3892/mco.2014.349. Epub 2014 Jul 15. Mol Clin Oncol. 2014. PMID: 25279191 Free PMC article.

10

Bortezomib and belinostat inhibit renal cancer growth synergistically by causing ubiquitinated protein accumulation and endoplasmic reticulum stress.

Asano T, Sato A, Isono M, Okubo K, Ito K, Asano T. Asano T, et al. Among authors: sato a. Biomed Rep. 2015 Nov;3(6):797-801. doi: 10.3892/br.2015.523. Epub 2015 Sep 29. Biomed Rep. 2015. PMID: 26623018 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,477 results

Search Page

Filters